Andrew Spokes latest buys and sells
25 additions in Andrew Spokes's latest 13F filing, largest first. The largest is the addition to Warner Bros Discovery Inc, $658.4M or 3.4% of the reported portfolio.
Key facts
- Additions
- 25
- Largest move
- Warner Bros Discovery Inc, $658.4M
- Latest filing
- Nov 16, 2026
From Farallon Capital Management's filing for (Q3 2026), filed , against the filing for Jun 30, 2026.
| # | Stock | Move | Shares | Size | Of portfolio |
|---|---|---|---|---|---|
| 1 | Warner Bros Discovery Incno ticker on file | ▲ Added 76% | +21.27M | $658.4M | 3.43% |
| 2 | Roivant Sciences LtdROIV | ▲ Added 52% | +7.44M | $272M | 1.42% |
| 3 | Strategy Incno ticker on file | ▲ Added 310% | — | $248.2M | 1.29% |
| 4 | Bridgebio Pharma IncBBIO | ▲ Added 33% | +3.5M | $230.6M | 1.20% |
| 5 | Natera IncNTRA | ▲ Added 17% | +381.33K | $157.6M | 0.82% |
| 6 | Biogen IncBIIB | ▲ Added 859% | +609.87K | $137.8M | 0.72% |
| 7 | Broadcom IncAVGO | ▲ Added 21% | +244.06K | $85.7M | 0.45% |
| 8 | Exelixis IncEXEL | ▲ Added 9.1% | +1.23M | $71.7M | 0.37% |
| 9 | AramarkARMK | ▲ Added 27% | +980.75K | $52.5M | 0.27% |
| 10 | Strategy Incno ticker on file | ▲ Added more than 10× | — | $42.6M | 0.22% |
| 11 | Boston Scientific CorpBSX | ▲ Added 7.3% | +765.95K | $33.4M | 0.17% |
| 12 | Avalo Therapeutics IncAVTX | ▲ Added 59% | +1.48M | $22.6M | 0.12% |
| 13 | Immunovant IncIMVT | ▲ Added 11% | +665.85K | $22.5M | 0.12% |
| 14 | Johnson & JohnsonJNJ | ▲ Added 18% | +72.42K | $19.2M | 0.10% |
| 15 | Brightspring Health Services IncBTSG | ▲ Added 18% | +311.03K | $17.7M | 0.09% |
| 16 | Liquidia CorporationLQDA | ▲ Added 6.5% | +541.21K | $16.4M | 0.09% |
| 17 | Protagonist Therapeutics IncPTGX | ▲ Added 1.4% | +88.89K | $12.5M | 0.07% |
| 18 | Synopsys IncSNPS | ▲ Added 3.4% | +28.29K | $12.3M | 0.06% |
| 19 | Acadia Healthcare CompanyACHC | ▲ Added 9.2% | +387.48K | $10.7M | 0.06% |
| 20 | JOYY IncJOYY | ▲ Added 17% | +121.03K | $9.7M | 0.05% |
| 21 | Rio Tinto PLCRIO | ▲ Added 19% | +35.43K | $3.3M | 0.02% |
| 22 | Abivax SAABVX | ▲ Added 15% | +18K | $1.8M | 0.01% |
| 23 | Beam Therapeutics IncBEAM | ▲ Added 0.4% | +39.92K | $976.1K | 0.01% |
| 24 | Agios Pharmaceuticals IncAGIO | ▲ Added 0.4% | +21.9K | $728K | 0.00% |
| 25 | Vnet Group IncVNET | ▲ Added 1.7% | +33.07K | $183.5K | 0.00% |
Questions and answers
What did Andrew Spokes buy last quarter?
The largest purchases in the latest 13F filing: Warner Bros Discovery Inc, $658.4M; ROIV, $272M; Strategy Inc, $248.2M; BBIO, $230.6M; NTRA, $157.6M; BIIB, $137.8M.
How is the size of a buy or sell worked out?
As the change in shares at the price the filing implies for the quarter's end (reported value divided by shares) — an estimate of the trade, not what was paid. A position sold out is sized at its value in the previous filing.
Learn
Cite this page
Funkfolio, “Andrew Spokes: buys and sells, Q3 2026 13F”, data as of 16 November 2026. https://funkfolio.com/gurus/activity?type=added&investor=farallon
Underlying data: SEC EDGAR, Form 13F-HR.
Source: SEC EDGAR, Form 13F-HR. A move is a change in share count between an investor's latest filing and the one before; a share split in between is allowed for where one is on record. Size is the shares bought or sold at the price the filing implies for the period end (reported value ÷ shares) — an estimate of the trade, not what was paid — and a position sold out is sized at its value in the previous filing. “Of portfolio” sets that size against the portfolio reported for the period. Only each investor's 150 largest positions and 50 largest exits are read. Filings appear up to 45 days after the quarter ends; none of this is advice.